Cisco
CSCO
Alibaba
BABA
Disney
DIS
4
Apple
AAPL
5
Qualcomm
QCOM
US Stock MarketDetailed Quotes
LRMR Larimar Therapeutics
- 2.250
- -0.060-2.60%
Close Mar 26 16:00 ET
144.06MMarket Cap-1.70P/E (TTM)
2.321High2.190Low975.42KVolume2.320Open2.310Pre Close2.18MTurnover3.11%Turnover RatioLossP/E (Static)64.03MShares11.20052wk High0.84P/B70.53MFloat Cap2.19052wk Low--Dividend TTM31.35MShs Float664.320Historical High--Div YieldTTM5.67%Amplitude1.530Historical Low2.239Avg Price1Lot Size
Larimar Therapeutics News
JonesTrading Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $14
Baird Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Cuts Target Price to $10
Truist Financial Maintains Larimar Therapeutics(LRMR.US) With Buy Rating
Larimar Therapeutics Analyst Ratings
Wedbush Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Cuts Target Price to $17
Analysts' Opinions Are Mixed on These Healthcare Stocks: Opthea Limited Sponsored ADR (OPT) and Larimar Therapeutics (LRMR)
William Blair Maintains Larimar Therapeutics(LRMR.US) With Buy Rating
JMP Securities Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $21
William Blair Sticks to Their Buy Rating for Larimar Therapeutics (LRMR)
Wedbush Cuts Price Target on Larimar Therapeutics to $17 From $22, Maintains Outperform Rating
JMP Securities Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $21
Truist Financial Initiates Larimar Therapeutics(LRMR.US) With Buy Rating, Announces Target Price $18
Truist Sees 'Significant Upside' for Larimar Therapeutics, Starts With a Buy
Truist Initiates Larimar Therapeutics at Buy With $18 Price Target
Larimar Therapeutics Analyst Ratings
H.C. Wainwright Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $15
JMP Securities Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $21
JMP Securities Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $21
JMP Securities Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Maintains Target Price $21
Baird Maintains Larimar Therapeutics(LRMR.US) With Buy Rating, Cuts Target Price to $13
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call